These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
307 related articles for article (PubMed ID: 21095255)
1. Serological response and persistence in schoolchildren with high baseline seropositive rate after receiving 2009 pandemic influenza A(H1N1) vaccine. Chao DY; Cheng KF; Hsieh YH; Li TC; Wu TN; Chen CY; Tsai CA; Chen JH; Chiu HT; Lu JJ; Su MC; Liao YH; Vaccine; 2011 Jan; 29(4):617-23. PubMed ID: 21095255 [TBL] [Abstract][Full Text] [Related]
2. Antibody persistence and response to 2010-2011 trivalent influenza vaccine one year after a single dose of 2009 AS03-adjuvanted pandemic H1N1 vaccine in children. Gilca V; De Serres G; Hamelin ME; Boivin G; Ouakki M; Boulianne N; Sauvageau C; Dionne M; Gilca R; Skowronski D Vaccine; 2011 Dec; 30(1):35-41. PubMed ID: 22063386 [TBL] [Abstract][Full Text] [Related]
3. Immune response to 2009 pandemic H1N1 influenza virus A monovalent vaccine in children with cancer. Yen TY; Jou ST; Yang YL; Chang HH; Lu MY; Lin DT; Lin KH; Huang LM; Chang LY Pediatr Blood Cancer; 2011 Dec; 57(7):1154-8. PubMed ID: 21425448 [TBL] [Abstract][Full Text] [Related]
4. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming? Walter EB; Neuzil KM; Zhu Y; Fairchok MP; Gagliano ME; Monto AS; Englund JA Pediatrics; 2006 Sep; 118(3):e570-8. PubMed ID: 16950948 [TBL] [Abstract][Full Text] [Related]
5. Response to 2009 pandemic and seasonal influenza vaccines co-administered to HIV-infected and HIV-uninfected former drug users living in a rehabilitation community in Italy. Pariani E; Boschini A; Amendola A; Poletti R; Anselmi G; Begnini M; Ranghiero A; Cecconi G; Zanetti AR Vaccine; 2011 Nov; 29(49):9209-13. PubMed ID: 21974995 [TBL] [Abstract][Full Text] [Related]
6. Pandemic influenza A/H1N1 vaccine administered sequentially or simultaneously with seasonal influenza vaccine to HIV-infected children and adolescents. Esposito S; Tagliaferri L; Daleno C; Valzano A; Picciolli I; Tel F; Prunotto G; Serra D; Galeone C; Plebani A; Principi N Vaccine; 2011 Feb; 29(8):1677-82. PubMed ID: 21199699 [TBL] [Abstract][Full Text] [Related]
7. [A survey of levels of antibodies against influenza viruses in the population of Wuxi City]. You FX; Sun N; Ma GY; Wang MM; Sa D; Shi C; Wu JL; Lin X; Xiao Y; Qian YH; Jiang Y; Xie J; Ji YY; Guan HX Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2011 Oct; 25(5):351-4. PubMed ID: 22338222 [TBL] [Abstract][Full Text] [Related]
8. Immunization with trivalent inactivated influenza vaccine in partially immunized toddlers. Englund JA; Walter EB; Gbadebo A; Monto AS; Zhu Y; Neuzil KM Pediatrics; 2006 Sep; 118(3):e579-85. PubMed ID: 16950949 [TBL] [Abstract][Full Text] [Related]
9. Immunogenicity and reactogenicity of 1 versus 2 doses of trivalent inactivated influenza vaccine in vaccine-naive 5-8-year-old children. Neuzil KM; Jackson LA; Nelson J; Klimov A; Cox N; Bridges CB; Dunn J; DeStefano F; Shay D J Infect Dis; 2006 Oct; 194(8):1032-9. PubMed ID: 16991077 [TBL] [Abstract][Full Text] [Related]
10. Immunogenicity and safety of monovalent influenza A (H1N1) 2009 in HIV-infected Thai children. Phongsamart W; Sirisanthana V; Wittawatmongkol O; Maleesatharn A; Sudjaritruk T; Chearskul P; Aurpibul L; Sirisanthana T; Chokephaibulkit K Vaccine; 2011 Nov; 29(47):8705-11. PubMed ID: 21893147 [TBL] [Abstract][Full Text] [Related]
11. Effect of prior vaccination with a seasonal trivalent influenza vaccine on the antibody response to the influenza pandemic H1N1 2009 vaccine: a randomized controlled trial. Uno S; Kimachi K; Kei J; Miyazaki K; Oohama A; Nishimura T; Ibaragi K; Odoh K; Kudo Y; Kino Y Microbiol Immunol; 2011 Nov; 55(11):783-9. PubMed ID: 21895745 [TBL] [Abstract][Full Text] [Related]
12. AF03-adjuvanted and non-adjuvanted pandemic influenza A (H1N1) 2009 vaccines induce strong antibody responses in seasonal influenza vaccine-primed and unprimed mice. Caillet C; Piras F; Bernard MC; de Montfort A; Boudet F; Vogel FR; Hoffenbach A; Moste C; Kusters I Vaccine; 2010 Apr; 28(18):3076-9. PubMed ID: 20193791 [TBL] [Abstract][Full Text] [Related]
13. Long-term immunogenicity of a virosomal subunit inactivated influenza vaccine in children with asthma. Zuccotti G; Amendola A; Viganò A; Pariani E; Zappa A; Pogliani L; Giacomet V; Savarino A; Podestà A; Rottoli A; Tanzi E; Zanetti A; Radaelli G Vaccine; 2007 Sep; 25(37-38):6692-8. PubMed ID: 17697730 [TBL] [Abstract][Full Text] [Related]
14. Improved serological response to H1N1 monovalent vaccine associated with viral suppression among HIV-1-infected patients during the 2009 influenza (H1N1) pandemic in the Southern Hemisphere. Maruszak H; Jeganathan S; Smith DE; Robertson P; Barnes T; Furner V HIV Med; 2012 Jul; 13(6):352-7. PubMed ID: 22296264 [TBL] [Abstract][Full Text] [Related]
15. Influenza A (H1N1) 2009 two-dose immunization of US children: an observer-blinded, randomized, placebo-controlled trial. Plennevaux E; Blatter M; Cornish MJ; Go K; Kirby D; Wali M; Reeves-Hoché MK; Denis M Vaccine; 2011 Feb; 29(8):1569-75. PubMed ID: 21219979 [TBL] [Abstract][Full Text] [Related]
16. Safety and immunogenicity of a trivalent single dose seasonal influenza vaccine containing pandemic A(H1N1) antigen in younger and elderly subjects: a phase III open-label single-arm study. Loebermann M; Anders G; Brestrich G; Fritzsche C; Klammt S; Boršo D; Frimmel S; Riebold D; Reisinger EC Vaccine; 2011 Feb; 29(6):1228-34. PubMed ID: 21167116 [TBL] [Abstract][Full Text] [Related]
17. Immunogenicity and safety of a monovalent vaccine for the 2009 pandemic influenza virus A (H1N1) in children and adolescents. Lu CY; Shao PL; Chang LY; Huang YC; Chiu CH; Hsieh YC; Lin TY; Huang LM Vaccine; 2010 Aug; 28(36):5864-70. PubMed ID: 20600484 [TBL] [Abstract][Full Text] [Related]
18. Low rate of seroconversion after vaccination with a split virion, adjuvanted pandemic H1N1 influenza vaccine in HIV-1-infected patients. Bickel M; Wieters I; Khaykin P; Nisius G; Haberl A; Stephan C; Von Hentig N; Herrmann E; Doerr HW; Brodt HR; Allwinn R AIDS; 2010 Jun; 24(9):F31-5. PubMed ID: 20559034 [TBL] [Abstract][Full Text] [Related]
19. Immunogenicity and safety of inactivated monovalent 2009 H1N1 influenza A vaccine in immunocompromised children and young adults. Hakim H; Allison KJ; Van De Velde LA; Li Y; Flynn PM; McCullers JA Vaccine; 2012 Jan; 30(5):879-85. PubMed ID: 22155630 [TBL] [Abstract][Full Text] [Related]
20. Poor seroprotection but allosensitization after adjuvanted pandemic influenza H1N1 vaccine in kidney transplant recipients. Fairhead T; Hendren E; Tinckam K; Rose C; Sherlock CH; Shi L; Crowcroft NS; Gubbay JB; Landsberg D; Knoll G; Gill J; Kumar D Transpl Infect Dis; 2012 Dec; 14(6):575-83. PubMed ID: 22999005 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]